INTERNATIONAL PATENT: COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. FILES APPLICATION FOR "STING AGONISM FOR ANTIGEN SPECIFIC TOLERANCE"

GENEVA, Oct. 1 -- COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. (8045 Lamon Avenue #1202Skokie, IL 60077) filed a patent application (PCT/US2025/020439) for "STING AGONISM FOR ANTIGEN SPECIFIC TOLERANCE" on Mar 18, 2025. With publication no. WO/2025/199149, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PODOJIL, Joseph (C/o Cour Pharmaceuticals Development Company Inc.8045 Lamon Avenue, #1202Skokie, IL 60077), ELHOFY, Adam (C/o Cour Pharmaceuticals Development Company Inc.8045 Lamon Avenue, #1202Skokie, IL 60077)

Abstra...